Passkeytx
9 employees on LinkedIn · 3 known investors
Passkey operates Locksmith, a computational platform that uses human genetics, biology, and pharmacology to identify synergistic drug combinations from approved and late-stage drugs, allowing existing assets to be repurposed for new indications. The company partners with pharmaceutical firms to map clinic-ready combinations that bypass preclinical development and move directly to human trials, initially targeting complex diseases such as cancer.
Investors · 3
Frequently asked questions
- What does Passkeytx do?
- Passkey operates Locksmith, a computational platform that uses human genetics, biology, and pharmacology to identify synergistic drug combinations from approved and late-stage drugs, allowing existing assets to be repurposed for new indications. The company partners with pharmaceutical firms to map clinic-ready combinations that bypass preclinical development and move directly to human trials, initially targeting complex diseases such as cancer.
- Who are Passkeytx's investors?
- Passkeytx's investors include Bison Ventures, Breakout Ventures, Wireframe Ventures.